An in-depth examination of the relationship between circ-SMARCA5 and SRSF1 and its downstream network in GBM cells was carried out, with the goal of bolstering the case for circ-SMARCA5 as a GBM biomarker [116] (Figure 5 and Table 3). This evidence concerns the gene SRSF1 and glioblastoma.